An independent two-stage DCF analysis by a frontier AI model.
GE HealthCare operates a resilient business model anchored by its extensive installed base of medical imaging and diagnostic equipment. While capital purchases by hospitals can be cyclical, the recurring revenue generated from long-term service contracts provides a significant buffer and supports predictable free cash flow generation.
The spin-off has allowed the company to sharpen its focus and optimize its cost structure. With a solid pipeline of incremental innovations and digital enhancements to its core platforms, GE HealthCare is well-positioned to maintain its market leadership and deliver steady returns to shareholders over the long term.
An 8.0% growth rate reflects steady expansion driven by consistent demand for medical imaging and patient care solutions, alongside operational improvements following the spin-off.
A 9.0% discount rate accounts for the mature, stable nature of the healthcare equipment industry, balanced against the standard equity risk premium and the company's specific capital structure.
2.5% is a standard terminal rate for a mature industrial healthcare company, aligning with long-term macroeconomic growth expectations.
Intrinsic value per share under varying discount rate and terminal growth rate assumptions.
| WACC ↓ / Terminal → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 1.5% | $91.56 | $77.47 | $67.14 | $59.24 | $53.01 |
| 2.0% | $100.71 | $83.93 | $71.94 | $62.94 | $55.95 |
| 2.5% | $111.90 | $91.56 | $77.47 | $67.14 | $59.24 |
| 3.0% | $125.89 | $100.71 | $83.93 | $71.94 | $62.94 |
| 3.5% | $143.87 | $111.90 | $91.56 | $77.47 | $67.14 |
■ Undervalued vs current price ■ Overvalued vs current price
The 8.0% growth rate reflects a combination of modest revenue expansion in mature markets and anticipated margin improvements as the company optimizes operations post-spin-off.
The company's value is heavily dependent on its recurring service revenue, which is derived from its massive installed base of equipment worldwide, ensuring steady cash flow even during periods of lower capital spending by hospitals.
Operating as a standalone entity allows GE HealthCare to implement a more focused capital allocation strategy and improve operational efficiency, factors which are built into the cash flow projections.
Disclaimer: The numbers presented on this page are for educational and entertainment purposes only. They are the result of a deterministic mathematical model fed with assumptions generated by an Artificial Intelligence (Gemini 3.1). This does not constitute investment advice. Always conduct your own due diligence before investing in the stock market.